Provided by Tiger Trade Technology Pte. Ltd.

Takeda Pharmaceutical Co Ltd

17.82
-0.2600-1.44%
Pre-market: 17.820.00000.00%04:00 EDT
Volume:2.89M
Turnover:51.42M
Market Cap:56.30B
PE:79.30
High:17.86
Open:17.79
Low:17.61
Close:18.08
52wk High:18.90
52wk Low:12.99
Shares:3.16B
Float Shares:3.06B
Volume Ratio:0.87
T/O Rate:0.09%
Dividend:0.62
Dividend Rate:3.50%
EPS(TTM):0.2247
EPS(LYR):0.2245
ROE:1.50%
ROA:2.47%
PB:1.17
PE(LYR):79.38

Loading ...

Takeda upgraded to Outperform from Market Perform at Bernstein

TIPRANKS
·
Apr 08

Denali Therapeutics Regains Full Rights to Dementia Drug Following Takeda Partnership Termination

MT Newswires Live
·
Apr 06

Denali Therapeutics regains full rights to DNL593

TIPRANKS
·
Apr 06

Analysts Are Bullish on Top Healthcare Stocks: Allogene Therapeutics (ALLO), Takeda Pharmaceutical Company (TAK)

TIPRANKS
·
Mar 31

Alumis' Drug 'Very Positive' for Treatment of Psoriasis, Systemic Lupus Erythematosus, Oppenheimer Says

MT Newswires Live
·
Mar 30

Takeda says Phase 3 zasocitinib pill clears plaque psoriasis skin in about 70% patients

Reuters
·
Mar 30

Takeda announces new data from Phase 3 studies of TAK-279

TIPRANKS
·
Mar 29

Takeda proposes Julie Kim for board election; Christophe Weber retires as CEO on June 24, 2026 shareholder vote

Reuters
·
Mar 26

Takeda Pharmaceutical to Book 1500 Billion Yen Restructuring Charge for AI-Driven Efficiency Overhaul

Stock News
·
Mar 25

Takeda Pharmaceutical Approves Restructuring Plan; Expects $1.26 Billion Annual Savings

MT Newswires Live
·
Mar 25

Market Chatter: Takeda, Eli Lilly to Face Class Action Over Actos Cancer Risk

MT Newswires Live
·
Mar 23

Takeda’s EXPLORHAE HAE Study in Egypt: Real‑World Data With Long‑Term Investor Upside

TIPRANKS
·
Mar 14

These 8 drugs could help fight dementia - and they're already on the market

Dow Jones
·
Mar 07

Takeda’s TAK-861 Narcolepsy Study Moves Forward, Extending the Long-Term Bet on Sleep Disorders

TIPRANKS
·
Mar 06

Takeda Advances Fazirsiran Phase 3 Liver Study, Keeping Rare-Disease Growth Story in Play

TIPRANKS
·
Mar 06

Sector Update: Health Care Stocks Advance Late Afternoon

MT Newswires Live
·
Mar 05

Market Chatter: Takeda Pharmaceutical to Cut 400 US Jobs, Invest in Blood Products

MT Newswires Live
·
Mar 05

Press Release: Alan Walshe Appointed General Manager of Takeda Canada

Dow Jones
·
Mar 02

Takeda, Protagonist announce FDA acceptance of rusfertide new drug application

TIPRANKS
·
Mar 02

Takeda’s Cuvitru Safety Study: What a New Japanese Registry Update Means for TAK Investors

TIPRANKS
·
Feb 21